{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:16:18Z","timestamp":1790864178892,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.medcli.2014.11.018","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T14:01:05Z","timestamp":1423058465000},"page":"281-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Catepsina K como biomarcador de afectaci\u00f3n \u00f3sea en la enfermedad de Gaucher tipo 1"],"prefix":"10.1016","volume":"145","author":[{"given":"Joaqu\u00edn","family":"Bobillo Lobato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Dur\u00e1n Parejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro J.","family":"N\u00fa\u00f1ez V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Jim\u00e9nez Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2014.11.018_bib0125","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2014.11.018_bib0130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of glucocerebrosidases. II. Evidence of an enzymatic deficiency in Gaucher's disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1016\/j.medcli.2014.11.018_bib0135","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.medcli.2014.11.018_bib0140","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10545-008-0832-y","article-title":"Non neuronopathic Gaucher disease reconsidered. Prevalence of neurological manifestations in Dutch cohort of type I Gaucher disease patients and a systematic review of the literature","volume":"1","author":"Biegstraaten","year":"2008","journal-title":"J Inherit Metab Dis."},{"key":"10.1016\/j.medcli.2014.11.018_bib0145","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1210\/jc.2011-0162","article-title":"Markers of bone turnover in Gaucher disease: Modeling the evolution of bone disease","volume":"96","author":"Van Dussen","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2014.11.018_bib0150","first-page":"33","article-title":"The bone in Gaucher disease","volume":"1","author":"Weinreb","year":"2007","journal-title":"Eur Musculoskelet Rev."},{"key":"10.1016\/j.medcli.2014.11.018_bib0155","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1148\/radiol.2292020296","article-title":"Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical MR imaging-initial experience","volume":"229","author":"Maas","year":"2003","journal-title":"Radiology."},{"key":"10.1016\/j.medcli.2014.11.018_bib0160","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am J Clin Pathol."},{"key":"10.1016\/j.medcli.2014.11.018_bib0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Proinflammatory cytokines and the pathogenesis of Gaucher's disease: Increased release of interleukin-6 and interleukin-1","volume":"90","author":"Allen","year":"1997","journal-title":"Quart J Med."},{"key":"10.1016\/j.medcli.2014.11.018_bib0170","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cyto.2005.03.006","article-title":"TNF-alpha levels and TNF-alpha gene polymorphism in type 1 Gaucher disease","volume":"31","author":"Altarescu","year":"2005","journal-title":"Cytokine."},{"key":"10.1016\/j.medcli.2014.11.018_bib0175","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.bbadis.2007.04.002","article-title":"Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease","volume":"1772","author":"Van Breemen","year":"2007","journal-title":"Biochim Biophys Acta."},{"issue":"1 Suppl.","key":"10.1016\/j.medcli.2014.11.018_bib0180","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","article-title":"Skeletal aspect of Gaucher disease: A review","volume":"75","author":"Wenstrup","year":"2002","journal-title":"Br J Radiol."},{"key":"10.1016\/j.medcli.2014.11.018_bib0185","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1042\/bj3310727","article-title":"Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix","volume":"331","author":"Kafienah","year":"1998","journal-title":"Biochem J."},{"key":"10.1016\/j.medcli.2014.11.018_bib0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1358\/dnp.2004.17.1.829022","article-title":"The role of cathepsin K in normal bone resorption","volume":"17","author":"Troen","year":"2004","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.medcli.2014.11.018_bib0195","doi-asserted-by":"crossref","first-page":"32347","DOI":"10.1074\/jbc.273.48.32347","article-title":"The collagenolytic activity of cathepsin K is unique among mammalian proteinases","volume":"273","author":"Garnero","year":"1998","journal-title":"J Biol Chem."},{"key":"10.1016\/j.medcli.2014.11.018_bib0200","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.V96.5.1969","article-title":"Pathologic gene expression in Gaucher disease: Up-regulation of cysteine proteinases including osteoclastic cathepsin K","volume":"96","author":"Moran","year":"2000","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2014.11.018_bib0205","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10545-005-0032-y","article-title":"Gaucher disease and bone: Laboratory and skeletal mineral density variations during a long period of enzyme replacement therapy","volume":"28","author":"Ciana","year":"2005","journal-title":"J Inherit Metab Dis."},{"key":"10.1016\/j.medcli.2014.11.018_bib0210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00223-001-2072-0","article-title":"Bone marker alterations in patients with type 1 Gaucher disease","volume":"72","author":"Ciana","year":"2003","journal-title":"Calcif Tissue Int."},{"key":"10.1016\/j.medcli.2014.11.018_bib0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/bcmd.2001.0479","article-title":"Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease","volume":"28","author":"Drugan","year":"2002","journal-title":"Blood Cells Mol Dis."},{"key":"10.1016\/j.medcli.2014.11.018_bib0220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cccn.2004.01.010","article-title":"Biochemical study on beta-glucosidase in individuals with Gaucher's disease and normal subjects","volume":"343","author":"Michelin","year":"2004","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.medcli.2014.11.018_bib0225","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollack","year":"1994","journal-title":"J Clin Invest."},{"key":"10.1016\/j.medcli.2014.11.018_bib0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1172-7-17","article-title":"Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula","volume":"7","author":"Giraldo","year":"2012","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.medcli.2014.11.018_bib0235","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00223-008-9143-4","article-title":"Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustat","volume":"83","author":"Mikosch","year":"2008","journal-title":"Calcif Tissue Int."},{"key":"10.1016\/j.medcli.2014.11.018_bib0240","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00198-006-0286-8","article-title":"Assessment of osteoclast number and function: Application in the development of new and improved treatment modalities for bone diseases","volume":"18","author":"Henriksen","year":"2007","journal-title":"Osteopor Int."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775314008793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775314008793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T17:25:59Z","timestamp":1598721959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775314008793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0025775314008793"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2014.11.018","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Catepsina K como biomarcador de afectaci\u00f3n \u00f3sea en la enfermedad de Gaucher tipo 1","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2014.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}